Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Higher levels of certain immune cells in hair follicles may contribute to alopecia areata.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

CD200 is not a reliable marker for identifying stem cells in all skin types.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Lnc056 helps hair follicle stem cells grow by increasing TRIP6 expression.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

SKH1 hairless mice have identifiable epidermal stem cells with specific markers.

The Fas/FasL pathway may play a role in alopecia areata.

MARCKSL1 is important for wound healing and could be a target to reduce scarring.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Myeloid cells can turn into skin and hair cells to help heal wounds.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Mouse skin has special cells in the epidermis that decrease with age and are linked to keratinocyte stem cells.